Search results
Results from the WOW.Com Content Network
This iterative process allows for the preparation of more complex peptides for use as active pharmaceutical ingredients (APIs), novel drug therapeutics, and general research applications. CPC Scientific has published some research articles that describe peptide synthesis methodologies, [ 3 ] [ 4 ] including a technique called hydrocarbon stapling.
Pharmaceutical compounding - the creation and dispensing of tailor-made medications - is the root of the pharmacy profession, often symbolised by the mortar and pestle. Compounding allows the pharmacist to work with the patient and the prescriber to customise medication to meet the patient’s specific needs.
It is a provider of custom and catalog peptides, custom oligos, antibodies, organic synthesis, and analytical services. Biomedical researchers worldwide in universities, biotech companies, private clinics, and government agencies use products from Bio-Synthesis, Inc. in studies ranging from PCR diagnostics to cancer research and the Human ...
For premium support please call: 800-290-4726 more ways to reach us
Sigma-Aldrich was created in 1975 by the merger of Sigma Chemical Company and Aldrich Chemical Company. It grew through various acquisitions until it had over 9,600 employees and was listed on the Fortune 1000. The company has two United States headquarters, in St. Louis and Burlington, MA and has operations in approximately 40 countries. [7]
It names the U.S.-based Artic Peptides, Strate Labs, Supopeptide, The Triggered Brand, and Unewlife as defendants, along with Britain’s B Eli Lilly sues online pharmacies to ban US imports of ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
At its R&D day in October 2010, BioMarin also announced a new program for a peptide therapeutic, vosoritide (BMN-111), for the treatment of achondroplasia. [14] In 2012, BioMarin acquired Zacharon Pharmaceuticals, a private biotechnology company based in San Diego focused on developing small molecules targeting pathways of glycan metabolism. [15]